Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review

OBJECTIVES: To summarize cost-effectiveness (CE) evidence of sacubitril/valsartan for the treatment of heart failure (HF) patients with reduced ejection fraction (HFrEF). The impact of different modeling approaches and parameters on the CE results is also described. METHODS: We conducted a systemati...

Descripción completa

Detalles Bibliográficos
Autores principales: Proudfoot, Clare, Gautam, Raju, Cristino, Joaquim, Agrawal, Rumjhum, Thakur, Lalit, Tolley, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060315/
https://www.ncbi.nlm.nih.gov/pubmed/35790595
http://dx.doi.org/10.1007/s10198-022-01485-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060315/
https://www.ncbi.nlm.nih.gov/pubmed/35790595
http://dx.doi.org/10.1007/s10198-022-01485-3

Ejemplares similares